SIGNAL GENETICS, INC.

Company

Viridian Therapeutics, Inc.\DE

Filed

February 20, 2015

Accession Number

0000902664-15-001332

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →